Advertisement
RayBiotech
RayBiotech

The Scientist

» disease/medicine, microbiology and ecology

Most Recent

image: Cancer Test Gets Bad Reviews

Cancer Test Gets Bad Reviews

By | May 22, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

2 Comments

image: How Castor Oil Stimulates Labor

How Castor Oil Stimulates Labor

By | May 21, 2012

Researchers flag the EP3 prostaglandin receptor as a key player in castor oil’s laxative and labor-inducing effects.

0 Comments

image: HIV Prevention Debate

HIV Prevention Debate

By | May 21, 2012

The suggested approval of a widely used antiretroviral drug to prevent HIV transmission in uninfected people sparks a debate about the possible dangers of such a move.

1 Comment

image: Wet Weather Stymies Insects

Wet Weather Stymies Insects

By | May 21, 2012

The rainiest April in 100 years is keeping many insects from flourishing in the United Kingdom.

1 Comment

image: Gene Therapy for Brain Disease

Gene Therapy for Brain Disease

By | May 16, 2012

Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.

0 Comments

image: How Prawns Lure Prey

How Prawns Lure Prey

By | May 15, 2012

Orange-loving Trinidad guppies are curiously attracted to orange spots on prawn pincers, which may make it easier for the predators to snatch them up.

1 Comment

image: Behavior Brief

Behavior Brief

By | May 15, 2012

A round-up of recent discoveries in behavior research

5 Comments

image: Does Education Boost Health?

Does Education Boost Health?

By | May 15, 2012

An examination of Swedish health and educational records suggests that more schooling results in healthier adults.

2 Comments

image: Bionic Eye Sees the Light

Bionic Eye Sees the Light

By | May 15, 2012

A light-powered retinal implant restores vision in rats.

0 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Teknova
Teknova
Advertisement
Life Technologies